Unsaturated nitrogen heterocyclic compounds useful as pde10 inhibitors
Patent Information
- Authority / Receiving Office
- US · United States
- Patent Type
- Applications(United States)
- Current Assignee / Owner
- INC AMGEN
- Publication Date
- 2014-07-31
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application is a continuation application of U.S. application Ser. No. 13 / 105,860, filed May 11, 2011, which claims the benefit of U.S. Provisional Application No. 61 / 334,525, filed May 13, 2010, which are hereby incorporated by reference in their entirety.FIELD OF THE INVENTION
[0002] Provided herein are certain unsaturated nitrogen heterocyclic compounds that are PDE10 inhibitors, pharmaceutical compositions containing such compounds, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, Huntington's disease, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.BACKGROUND
[0003] Neurotransmitters and hormones, as well as other types of extracellular signals such as light and odors, create intracellular signals by altering the amounts of cyclic nucleotide monophosphates (cAMP...